Pelster, M., Patnaik, A., Kristeleit, R., Kim, S. T., Putiri, E., Granlund, L., Herszdorfer, P., Sumrow, B., Oaknin, A. (2026). ASCEND: A phase 1/2, dose-escalation, optimization, and dose-expansion study to evaluate the safety and antitumor activity of CR-001 in adults with locally advanced or metastatic solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2693